Cargando…
Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
Insulin-sensitizing medications were originally used in psychiatric practice to treat weight gain and other metabolic side effects that accompany the use of mood stabilizers, antipsychotics, and some antidepressants. However, in recent studies these medications have been shown to cause improvement i...
Autores principales: | Toba-Oluboka, Temi, Vochosková, Kristýna, Hajek, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643486/ https://www.ncbi.nlm.nih.gov/pubmed/36347837 http://dx.doi.org/10.1038/s41398-022-02234-z |
Ejemplares similares
-
Update on GPCR-based targets for the development of novel antidepressants
por: Mantas, Ioannis, et al.
Publicado: (2021) -
A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007) -
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
por: Wei, Yan, et al.
Publicado: (2021) -
Quality improvement teaching at medical school: a student perspective
por: Nair, Pooja, et al.
Publicado: (2016) -
Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery
por: Bhattacharya, Saptarshi, et al.
Publicado: (2021)